These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29697655)

  • 1. [About the safety of application of nasal decongestants in the practice of pediatricians].
    Karpova EP; Tulupov DA; Vorob'eva MP; Fedotov FA; Dolginov DM; Bykov MV; Grabovskaya VA
    Vestn Otorinolaringol; 2018; 83(2):46-50. PubMed ID: 29697655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naphazoline intoxication in a child-a clinical and forensic toxicological case.
    Musshoff F; Gerschlauer A; Madea B
    Forensic Sci Int; 2003 Jul; 134(2-3):234-7. PubMed ID: 12850424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic stroke in a man with naphazoline abuse history.
    Costantino G; Ceriani E; Sandrone G; Montano N
    Am J Emerg Med; 2007 Oct; 25(8):983.e1-2. PubMed ID: 17920988
    [No Abstract]   [Full Text] [Related]  

  • 4. Bilateral thalamic stroke due to nasal ephedrine and naphazoline use.
    Liguori C; Garaci F; Romigi A; Mercuri NB; Marciani MG; Placidi F
    Neurol Sci; 2015 Jul; 36(7):1285-6. PubMed ID: 25527367
    [No Abstract]   [Full Text] [Related]  

  • 5. Intranasal lidocaine plus naphazoline nitrate improves surgical conditions and perioperative analgesia in septorhinoplasty surgery.
    Granier M; Dadure C; Bringuier S; Bonnet-Boyer MC; Ryckwaert Y; Loriaux E; Capdevila X
    Can J Anaesth; 2009 Feb; 56(2):102-8. PubMed ID: 19247757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electron microscopic studies of the rabbit nasal mucosa after short-term application of naphzoline nitrate].
    Agha-Mir-Salim P; Stange T; Knipping S; Jahnke V; Berghaus A
    Laryngorhinootologie; 2001 Jul; 80(7):389-93. PubMed ID: 11488150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do topical nasal decongestants affect polyps?
    Johansson L; Oberg D; Melén I; Bende M
    Acta Otolaryngol; 2006 Mar; 126(3):288-90. PubMed ID: 16618656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe poisoning with naphazoline: update from a therapeutic error].
    Díaz M; Granson E; Taiman J; Alava J; Gabrielli T; Mendoza L
    Arch Argent Pediatr; 2018 Aug; 116(4):e626-e629. PubMed ID: 30016045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nasal decongestants and eye drops: keep out of children's reach!].
    Poulin-Chartrand S
    Perspect Infirm; 2013; 10(2):63. PubMed ID: 23539872
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute coronary syndrome after nasal spray of oxymetazoline.
    Montastruc F; Montastruc G; Taudou MJ; Olivier-Abbal P; Montastruc JL; Bondon-Guitton E
    Chest; 2014 Dec; 146(6):e214-e215. PubMed ID: 25451367
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical Treatment of Nasal Airway Obstruction.
    Cox DR; Wise SK
    Otolaryngol Clin North Am; 2018 Oct; 51(5):897-908. PubMed ID: 29914725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naphazoline nasal drops intoxication in children.
    Vitezić D; Rozmanić V; Franulović J; Ahel V; Matesić D
    Arh Hig Rada Toksikol; 1994 Mar; 45(1):25-9. PubMed ID: 8067910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of laser Doppler flowmetry for the estimation of the influence of intranasal medications on microcirculation in nasal cavity mucosa].
    Svistunov AA; Mareev OV; Mareev GO; Bukreev IS
    Vestn Otorinolaringol; 2012; (3):34-8. PubMed ID: 22951682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brazilian Academy of Rhinology position paper on topical intranasal therapy.
    Mello JF; Mion Ode G; Andrade NA; Anselmo-Lima WT; Stamm AE; Almeida WL; Cavalcante Filho PO; Castro Jde C; Padua FG; Romano FR; Santos Rde P; Roitmann R; Voegels RL; Meirelles RC; Sá LC; Moacyr MT; Santos MC; Guimarães RE
    Braz J Otorhinolaryngol; 2013; 79(3):391-400. PubMed ID: 23743757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Danger of nasal vasoconstrictors in infants. Apropos of a case].
    Claudet I; Fries F
    Arch Pediatr; 1997 Jun; 4(6):538-41. PubMed ID: 9239269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal decongestants in the treatment of chronic nasal obstruction: efficacy and safety of use.
    Passàli D; Salerni L; Passàli GC; Passàli FM; Bellussi L
    Expert Opin Drug Saf; 2006 Nov; 5(6):783-90. PubMed ID: 17044805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary edema and prolonged awakening after nasal naphazoline application in a transspenoidal hypophysectomy patient.
    Klein KU; Wisser G; Engelhard K; Werner C
    J Neurosurg Anesthesiol; 2010 Jul; 22(3):269. PubMed ID: 20548172
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxymetazoline nasal spray.
    Graf P
    Laryngoscope; 1998 Aug; 108(8 Pt 1):1255. PubMed ID: 9707257
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion.
    Stübner UP; Toth J; Marks B; Berger UE; Burtin B; Horak F
    Arzneimittelforschung; 2001 Nov; 51(11):904-10. PubMed ID: 11765592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.